Furthermore, DNMT1 was identified as a potential target of miR-152, with luciferase reporter gene assays showing direct binding of miR-152 to DNMT1 3′UTR, leading to its inhibition in bladder cancer cells (60). The gene discussed is DNMT1; the disease is urinary bladder carcinoma.